Gene Editing Deal: Arbor and Chiesi Target Rare Diseases
Update: 2025-10-06
Description
Gene editing breakthrough? Arbor and Chiesi team up in a massive $2 billion deal to tackle rare diseases! Chiesi acquires ABO-101, a potential one-time cure for a devastating kidney disorder, offering hope where current treatments fall short. This alliance signals a major win for genetic medicine, defying funding challenges and paving the way for future cures.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
